Hemodynamic Monitoring Systems Market By Type (Monitoring Sensors, Pulmonary Artery Catheters, Oesophageal Doppler, Pulse Contour, and Volume Clamp), By Application (Invasive, Minimally Invasive, and Non-Invasive), By End User (Hospitals, Clinics, Ambulatory Care Center, Home Care Setting, and Others), Industry Trends, Estimation & Forecast, 2023-2030

The Hemodynamic Monitoring Systems market was valued at 1092.7 million US$ in 2022 and is projected to reach 1835.8 million US$ by 2030, at a CAGR of 6.7% during the forecast period.
  • Market Definition

    The hemodynamic monitoring system provides information about the patient’s circulation, perfusion, and oxygenation of the tissues and organs. The hemodynamic monitoring system also measures blood flow and oxygen in the blood. Hemodynamic monitoring is a way to see how well the heart is working.

    Market Dynamics

    Rising prevalence of cardiovascular diseases and diabetes is boosting the demand for hemodynamic monitoring systems. For instance, according to World Health Organization (WHO), Cardiovascular diseases (CVDs) are the number one cause of death globally, 17.9 million people die due to cardiovascular diseases each year, an estimate of 31% of deaths globally. More than 75% of cardiovascular disease deaths occur in lower and middle-income countries. Heart attack and stroke are the cause of 85% of CVD deaths globally. Hemodynamic monitoring systems measure blood pressure inside the veins, heart, and arteries. Further, increasing research study on hemodynamic monitoring systems and rising technological advancements in hemodynamic monitoring systems are key driving factors of the market. However, risks associated with the invasive hemodynamic monitoring system and product recall might hamper the market growth. For instance, the U.S. Food and Drug Administration has (FDA) has recalled Edwards Lifesciences 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters manufactured from December 26, 2017, to April 19, 2018, due to incorrect assembly that reversed the catheter lumens. The recall includes 1,426 devices in the United States. The FDA recall stated the inaccurate waveforms and pressure values might misguide a physician during placement of the catheter and increase the risk of blood vessel perforation. Moreover, the growing demand for patient monitoring devices in the homecare setting would provide lucrative opportunities for the market in the coming years.

    Market Segmentation

    The global hemodynamic monitoring systems market is mainly classified based on type, application, and end-user. Type is further segmented into Monitoring Sensors, Pulmonary Artery Catheters, Oesophageal Doppler, Pulse Contour, and Volume Clamp. By application, the market is divided into Invasive, Minimally Invasive, and Non-Invasive. By end-user, the market is further divided into Hospitals, Clinics, Ambulatory Care Center, Home Care Setting, and Others.

    Non-Invasive hemodynamic monitoring systems showed significant growth in 2019, owing to the increasing commercialization of regulatory approved products and partnerships between companies to develop advanced hemodynamic monitoring systems. For instance, Caretaker Medical and Mespere LifeSciences, have partnered to develop and deliver wireless CNIBP, Cerebral Oximetry, and other critical non-invasive hemodynamic measurements in a single monitoring platform. Caretaker wireless CNIBP and Vital Signs Monitor and the Mespere NeurOs are FDA Cleared, and CE-Mark certified.

    Regional Analysis

    Based on geography, the global hemodynamic monitoring systems market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

    North America was dominating the global hemodynamic monitoring systems market in 2019, due to the rising prevalence of cardiovascular diseases in North American regions. For instance, in 2019, 48% of adults in the United States have some form of cardiovascular disease, and it is expected to be more than 130 million cases by 2035 in the U.S. Moreover, technological advancement in hemodynamic monitoring systems, the partnership between companies to develop and supply hemodynamic monitoring systems, and increasing regulatory approval are some of the major factors driving the market demand. For instance, Edwards Lifesciences Corporation has received the U.S. Food and Drug Administration has (FDA) clearance for HemoSphere advanced monitoring platform. HemoSphere advanced monitoring platform provides clinicians with exceptional clarity on a patient’s hemodynamics and manages blood flow to help them make proactive.

    Competitive landscape

    Key players operating in the hemodynamic monitoring systems industry include Deltex Medical Group PLC, Edwards Lifesciences Corporation, Lidco Group, PULSION Medical Systems SE, CNSystems Medizintechnik GmbH, ICU Medical, Osypka Medical GmbH, Caretaker Medical, NI Medical, Cheetah Medical, Teleflex Incorporated, Uscom, LiDCO Group Plc, and Nihon Kohden Corporation.

    The increasing commercialization of regulatory approved hemodynamic monitoring systems, technological advancement, increasing research studies on hemodynamic monitoring systems, increasing partnership between companies to develop hemodynamic system and distribution agreement of noninvasive hemodynamic monitoring system are some of the strategies adopted by the major companies. For instance, on June 14, 2018, Cheetah Medical French distributor, SEBAC SA, has received an agreement to supply Starling SV non-invasive fluid management solutions to the public hospital system of Paris and its suburbs. The deal will last for four years with Assistance Publique des Hopitaux de Paris (APHP), and the agreement was valued by $3.6M (€3M). Starling SV Hemodynamic Monitoring System is a 100% noninvasive hemodynamic monitoring system used for volume management and perfusion optimization.

    Hemodynamic Monitoring Systems Market Key Segments

    By Type
    • Monitoring Sensors
    • Pulmonary Artery Catheters
    • Oesophageal Doppler
    • Pulse Contour
    • Volume Clamp

    By Application
    • Invasive
    • Minimally Invasive
    • Non-Invasive

    By End-User
    • Hospitals
    • Clinics
    • Ambulatory Care Center
    • Home Care Setting
    • Others

    Key Global Hemodynamic Monitoring Systems Industry Players
    • Deltex Medical Group PLC
    • Edwards Lifesciences Corporation
    • Lidco Group
    • PULSION Medical Systems SE
    • CNSystems Medizintechnik GmbH
    • ICU Medical
    • Osypka Medical GmbH
    • Caretaker Medical
    • NI Medical
    • Cheetah Medical
    • Teleflex Incorporated
    • Uscom
    • LiDCO Group Plc
    • Nihon Kohden Corporation

    keyboard_arrow_up
  • Table of Content

    1. Market Introduction
    1.1. Executive Summary
    1.2. Market Definition
    1.3. Market Scope

    2. Research Methodology
    2.1. Primary Research
    2.2. Research Methodology
    2.3. Assumptions & Exclusions
    2.4. Secondary data sources

    3. Hemodynamic Monitoring Systems Market Overview
    3.1. Report Segmentation & Scope
    3.2. Key Market Trend
    3.3. Drivers
    3.3.1. Rising Prevalence of Cardiovascular Diseases and Diabetes
    3.3.2. Increasing Research Study on Hemodynamic Monitoring Systems
    3.3.3. Rising Technological Advancements in Hemodynamic Monitoring Systems
    3.4. Restraints
    3.4.1. Risks Associated with Invasive Hemodynamic Monitoring System
    3.4.2. Product Recall
    3.5. Opportunity
    3.5.1. Growing Demand for Patient Monitoring Devices in Homecare Setting
    3.6. Porter’s Five Forces Analysis
    3.6.1. Porter’s Five Forces Analysis
    3.7. Market Share Analysis

    4. Type Overview
    4.1. Introduction
    4.1.1. Market Size & Forecast
    4.2. Monitoring Sensors
    4.2.1. Market Size & Forecast
    4.3. Pulmonary Artery Catheters
    4.3.1. Market Size & Forecast
    4.4. Oesophageal Doppler
    4.4.1. Market Size & Forecast
    4.5. Pulse Contour
    4.5.1. Market Size & Forecast
    4.6. Volume Clamp
    4.6.1. Market Size & Forecast

    5. Application Overview
    5.1. Introduction
    5.1.1. Market Size & Forecast
    5.2. Invasive
    5.2.1. Market Size & Forecast
    5.3. Minimally Invasive
    5.3.1. Market Size & Forecast
    5.4. Non-Invasive
    5.4.1. Market Size & Forecast

    6. End-User Overview
    6.1. Introduction
    6.1.1. Market Size & Forecast
    6.2. Hospitals
    6.2.1. Market Size & Forecast
    6.3. Clinics
    6.3.1. Market Size & Forecast
    6.4. Ambulatory Care Center
    6.4.1. Market Size & Forecast
    6.5. Home Care Setting
    6.5.1. Market Size & Forecast
    6.6. Others
    6.6.1. Market Size & Forecast

    7. Hemodynamic Monitoring Systems Market Regional Overview
    7.1. Introduction
    7.1.1. Market Size & Forecast
    7.2. North America Hemodynamic Monitoring Systems Market
    7.2.1. North America Market Size & Forecast, By Country
    7.2.2. North America Market Size & Forecast, By Type
    7.2.3. North America Market Size & Forecast, By Application
    7.2.4. North America Market Size & Forecast, By End User
    7.2.5. U.S.
    7.2.5.1. Market Size and Forecast
    7.2.6. Canada
    7.2.6.1. Market Size and Forecast
    7.2.7. Mexico
    7.2.7.1. Market Size and Forecast
    7.3. Europe Hemodynamic Monitoring Systems Market
    7.3.1. Europe Market Size & Forecast, By Country
    7.3.2. Europe Market Size & Forecast, By Type
    7.3.3. Europe Market Size & Forecast, By Application
    7.3.4. Europe Market Size & Forecast, By End User
    7.3.5. Germany
    7.3.5.1. Market Size and Forecast
    7.3.6. France
    7.3.6.1. Market Size and Forecast
    7.3.7. UK
    7.3.7.1. Market Size and Forecast
    7.3.8. Italy
    7.3.8.1. Market Size and Forecast
    7.3.9. Spain
    7.3.9.1. Market Size and Forecast
    7.3.10. Rest of Europe
    7.3.10.1. Market Size and Forecast
    7.4. Asia-Pacific Hemodynamic Monitoring Systems Market
    7.4.1. Asia-Pacific Market Size & Forecast, By Country
    7.4.2. Asia-Pacific Market Size & Forecast, By Type
    7.4.3. Asia-Pacific Market Size & Forecast, By Application
    7.4.4. Asia-Pacific Market Size & Forecast, By End User
    7.4.5. Japan
    7.4.5.1. Market Size and Forecast
    7.4.6. China
    7.4.6.1. Market Size and Forecast
    7.4.7. Australia
    7.4.7.1. Market Size and Forecast
    7.4.8. India
    7.4.8.1. Market Size and Forecast
    7.4.9. South Korea
    7.4.9.1. Market Size and Forecast
    7.4.10. Rest of Asia-Pacific
    7.4.10.1. Market Size and Forecast
    7.5. South America Hemodynamic Monitoring Systems Market
    7.5.1. South America Market Size & Forecast, By Country
    7.5.2. South America Market Size & Forecast, By Type
    7.5.3. South America Market Size & Forecast, By Application
    7.5.4. South America Market Size & Forecast, By End User
    7.5.5. Brazil
    7.5.5.1. Market Size and Forecast
    7.5.6. Argentina
    7.5.6.1. Market Size and Forecast
    7.5.7. Rest of South America
    7.5.7.1. Market Size and Forecast
    7.6. Middle East & Africa Hemodynamic Monitoring Systems Market
    7.6.1. Middle East & Africa Market Size & Forecast, By Country
    7.6.2. Middle East & Africa Market Size & Forecast, By Type
    7.6.3. Middle East & Africa Market Size & Forecast, By Application
    7.6.4. Middle East & Africa Market Size & Forecast, By End User
    7.6.5. GCC Countries
    7.6.5.1. Market Size and Forecast
    7.6.6. Egypt
    7.6.6.1. Market Size and Forecast
    7.6.7. South Africa
    7.6.7.1. Market Size and Forecast
    7.6.8. Rest of Middle East & Africa
    7.6.8.1. Market Size and Forecast

    8. Company Profile
    8.1. Deltex Medical Group PLC
    8.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    8.1.2. Deltex Medical Group PLC Product Category, Application, and Specification
    8.1.3. Deltex Medical Group PLC Financial Performance (2016-2018)
    8.1.4. Main Business/Business Overview
    8.2. Edwards Lifesciences Corporation
    8.3. Lidco Group
    8.4. PULSION Medical Systems SE
    8.5. CNSystems Medizintechnik GmbH
    8.6. ICU Medical
    8.7. Osypka Medical GmbH
    8.8. Caretaker Medical
    8.9. NI Medical
    8.10. Cheetah Medical
    8.11. Teleflex Incorporated
    8.12. Uscom
    8.13. LiDCO Group Plc
    8.14. Nihon Kohden Corporation

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Report Provides?

• Full in-depth analysis of the parent Industry
• Important changes in market and its dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional growth potential

error: Right-Click on this site is Disabled